Therapeutic target database 2026: facilitating targeted therapies and precision medicine
Nucleic Acids Research · 06.01.2026 · 54 (D1) · D1692-D1701
DOI: 10.1093/nar/gkaf1154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 17.11.2025. Verfasst von Yintao Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Precision Medicine, Molecular Targeted Therapy, Drug Discovery, Databases, Pharmaceutical. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Funding of China, National Key R&D Program of People's Republic of China, Natural Science Foundations of Zhejiang.
Abstract (Originalsprache)
Development of targeted therapeutics begins with the discovery and validation of therapeutic targets, which builds the foundation for rational drug design. Extensive information on target–disease associations, target perturbation profiles, drug bioactivity landscapes, and clinical profiles is critical for identifying disease-relevant targets, elucidating their biological functions, and assessing the therapeutic potential. Therapeutic target database 2026 represents a major update that expands multiple layers of data essential for drug discovery. Key expansions include (i) 306 247 target–disease associations covering 2912 targets, (ii) 10 506 perturbation profiles triggered by genetic modification or chemical interference on 2368 targets, (iii) multidimensional activity landscapes of 17 806 drugs, encompassing cytotoxic, antimicrobial-, and molecular-level activities, and (iv) abundant clinical profiles for 2234 approved drugs. As a result, this update provides expanded and curated information on 3798 targets and 40 398 drugs. To enhance usability and scalability, the database framework has been rebuilt, which can be freely accessible without any login requirement at https://idrblab.org/ttd/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.
- Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
- Wisdom Lake Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.
- Chu Kochen Honors College, Zhejiang University, Hangzhou 310058, China.
- School of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
- Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China.
ORCID-Profile: Yintao Zhang, Ying Zhou, Songlin Lu, Xin Liu, Feng Zhu, Yuzong Chen
Förderung
- National Natural Science Funding of China
- National Key R&D Program of People's Republic of China
- Natural Science Foundations of Zhejiang
- Postdoctoral Fellowship Program of CPSF
- Zhejiang University
- National Key R&D Program of People’s Republic of China
Zitieren
APA
Zhang, Y., Zhou, Y., Xu, H., Jiang, W., Li, B., Lai, D., Wan, C., Wang, S., Zhao, M., Tan, Y., Lu, S., Fan, T., Liu, X., Zhu, F., & Chen, Y. (2026). Therapeutic target database 2026: facilitating targeted therapies and precision medicine. Nucleic Acids Research, 54(D1), D1692-D1701. https://doi.org/10.1093/nar/gkaf1154
Vancouver
Zhang Y, Zhou Y, Xu H, Jiang W, Li B, Lai D, et al. Therapeutic target database 2026: facilitating targeted therapies and precision medicine. Nucleic Acids Research. 2026;54(D1):D1692-D1701. doi:10.1093/nar/gkaf1154
BibTeX
@article{Zhang2026,
author = {Zhang, Yintao and Zhou, Ying and Xu, Hangwei and Jiang, Wanghao and Li, Bo and Lai, Dianyu and Wan, Cong and Wang, Shanshan and Zhao, Mingxiao and Tan, Ying and Lu, Songlin and Fan, Tingting and Liu, Xin and Zhu, Feng and Chen, Yuzong},
title = {Therapeutic target database 2026: facilitating targeted therapies and precision medicine},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {D1},
pages = {D1692--D1701},
doi = {10.1093/nar/gkaf1154}
}
EUVIMED